oral cholate challenge duo) test (HepQuant LLC)
90
Structured Review
HepQuant LLC
oral cholate challenge duo) test
Oral Cholate Challenge Duo) Test, supplied by HepQuant LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cholate+challenge+tests/oral+cholate+challenge+test+hepquant+duo/pmc11636074-101-5-8
Average 90 stars, based on 1 article reviews
Oral Cholate Challenge Duo) Test, supplied by HepQuant LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cholate+challenge+tests/oral+cholate+challenge+test+hepquant+duo/pmc11636074-101-5-8
Average 90 stars, based on 1 article reviews
oral cholate challenge duo) test - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Assessment of the performance of a dual-sample oral cholate challenge test: The HepQuant DuO test. Article Snippet: Background: Liver health is currently evaluated using nonspecific blood tests, fibrosis surrogates, and invasive procedures, none of which directly measure liver function and physiology.. The validated HepQuant SHUNT test quantifies liver function and physiology and is linked to clinical outcomes.. Herein we present the reliability of a simplified version, the dual-sample oral cholate challenge (HepQuant DuO) test. Article Title: Measuring the risk of clinical adverse events (RISK ACE) by quantifying liver function: A patient-centric model. Article Snippet: Identifying the patients with compensated advanced chronic liver disease (cACLD) who are at risk for clinical decompensation is a goal of clinical management [1].. Early detection of those at risk for liver decompensation to target clinical intervention is crucial for reducing mortality, decreasing healthcare costs, and improving quality of life.. Staging of liver fibrosis by liver biopsy and measurement of portal pressure by hepatic venous pressure gradient correlate with risk for clinical outcome [2,3], however, both tests are invasive, carry risk for complications, and are not embraced by patients. Article Title: Cholate Shunt, Oral Cholate Challenge and Endoscopic Lesions of Portal Hypertension: The SHUNT-V Study. Article Snippet: McRae have pending patents related to the Article Title: Cost-effectiveness of an oral cholate challenge test for the management of patients at risk for large esophageal varices. Article Snippet: GT Everson, in conjunction with the University of Colorado Denver Anschutz Medical Campus, has patents, both issued and pending, related to the Diagnostic Assay:Article Title: Letter: Enhancing the Diagnostic Performance of the Oral Cholate Challenge Test: Implications for Avoidance of Potentially Unnecessary Endoscopy. Article Snippet: 1Southern California Research Center, Coronado, California, USA | 2Mayo Clinic, Jacksonville, Florida, USA | 3The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, USA | 4Bon Secours Liver Institute of Virginia, Richmond, Virginia, USA | 5Mayo Clinic, Rochester, Minnesota, USA | 6Saint Louis University School of Medicine, St. Louis, Missouri, USA | 7Syneos Health, Morrisville, North Carolina, USA | 8Custom DX Solutions LLC, Houston, Texas, USA | 9HepQuant, LLC, Denver, Colorado, USA Derivative Assay:Article Title: Letter: Enhancing the Diagnostic Performance of the Oral Cholate Challenge Test: Implications for Avoidance of Potentially Unnecessary Endoscopy. Article Snippet: 1Southern California Research Center, Coronado, California, USA | 2Mayo Clinic, Jacksonville, Florida, USA | 3The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, USA | 4Bon Secours Liver Institute of Virginia, Richmond, Virginia, USA | 5Mayo Clinic, Rochester, Minnesota, USA | 6Saint Louis University School of Medicine, St. Louis, Missouri, USA | 7Syneos Health, Morrisville, North Carolina, USA | 8Custom DX Solutions LLC, Houston, Texas, USA | 9HepQuant, LLC, Denver, Colorado, USA |